Mismatch repair deficiency is not applicable as biomarker in cervical cancer, yet msh-2 has strong prognostic value
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER(2022)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined